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High blood pressure is the greatest risk factor for diseases such as hypertension, stroke, and 
cardiovascular disease.  Blood pressure control has become a global public health priority. Nitric 
oxide (NO), which can be converted from nitrate, has been reported to reduce blood pressure. 
Clinical trials have been conducted to test the effect of dietary intake rich in nitrate on reduction 
of blood pressure and the results have been inconsistent. We aimed to conduct a meta-analysis of 
randomized clinical trials to evaluate the impact of dietary nitrate on blood pressure (BP) 
reduction.  
Methods 
Pubmed, EMBASE, and Web of Science were systematically searched from inception until July 
2018. We included the randomized clinical trials that examined the effect of dietary nitrate 
supplementation like beetroot supplementation in reducing systolic blood pressure (SBP) and 
diastolic blood pressure (DBP) compared to taking placebo or low nitrate supplementation. A 
random-effects meta-analysis was conducted to evaluate the intervention of nitrate diet on the 
control of BP. 
Results 
A total of 41 trials including 733 participants (with 5 to 65 participants per study) were eligible. 
The duration of each intervention ranged from 3 hours to 12 weeks with the median value of 3 
days (25%-75% quartile range equal to 1-7 days).  21 out of 41 studies showed that dietary 
nitrate was associated with a significant decline in SBP compared to placebo, while only 12 out 
of the 21 above studies indicated that dietary nitrate was also associated with a significant DBP 
reduction. There were 3 studies where dietary nitrate significantly reduced in DBP but not SBP. 
Overall, blood pressure (BP) reductions were -3.12 mm Hg (95% CI, -4.59 to -1.54) for systolic 
and -1.43 mm Hg (95% CI, -2.55 to -0.30) for diastolic. The greater effect size on BP reduction 
was found among the groups with the interventions of beetroot juice and nitrate-depleted placebo 
(MD in SBP for beetroot juice=-4.68 mmHg, 95% CI: -6.57 to -2.01, MD in DBP for beetroot 
juice=-2.35 mmHg, 95% CI: -3.86 to -0.84, MD in SBP for nitrate-depleted placebo=-4.40 
mmHg, 95% CI: -6.79 to -2.01, and MD in DBP for nitrate-depleted placebo=-2.10 mmHg, 95% 
3 
 
CI: -3.85 to -0.35). The higher impact of beetroot and inorganic nitrate supplementation on BP 
reduction found in older subjects was mostly associated with the structural changes in their 
arteries and especially with large artery stiffness. Our meta-regression analysis also demonstrated 
a significant negative relationship between age and the treatment effect on DBP after beetroot 
and inorganic nitrate consumption (slope=-0.0696; p=0.031). 
Conclusion 
Overall, dietary nitrate showed significant effect in reducing SBP, while that in reducing DBP is 
less consistent. This study provided insight to potential complementary therapies for acute blood 
pressure lowering effect in populations, particularly when internal source of NO suffers from 
dysfunction.  Dietary nitrate is an essential supplement for the prevention and treatment of 
hypertension. Public health leaders should implement effective interventions that incorporate 
individual behavior changes to increase intake of nitrate diet and environmental changes to 
encourage and promote greater access to healthier food. 
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Noncommunicable diseases (NCDs), also known as chronic disease, leads to the death of 41 
million people each year, equivalent to 71% of all deaths globally according to the World Health 
Organization (WHO). A major challenge to meeting the 2030 Sustainable Development Goals 
(SDGs), NCDs have four key metabolic risk factors: 1) raised blood pressure (hypertension), 2) 
overweight, 3) hyperglycemia (high blood glucose levels) and 4) hyperlipidemia (high levels of 
fat in the blood) (1). By changing the structure of the arteries, hypertension is a major factor in 
stroke, cardiovascular disease, kidney failure, other diseases (2, 3). Hypertension as the leading 
risk factor contributed to about 40% of people worldwide according to WHO and 1/3 of U.S. 
adults based on CDC (4,5). In both developing and developed countries, 51% of stroke and 45% 
of ischaemic heart disease deaths are due to high systolic blood pressure (SBP) (4). About 50 
million people in the United States and one billion people globally suffer hypertension (6). 
People who are normotensive at age 55 have a 90% lifetime risk for developing hypertension (7). 
For individuals older than 50 years, SBP greater than 140 mmHg is a more important 
cardiovascular disease (CVD) risk factor than DBP;  for individuals between 40–70 years of age, 
each increment of 20 mmHg in SBP or 10 mmHg in DBP can double the risk of CVD across the 
BP range from 115/75 to 185/115 mmHg (7).  
Therefore blood pressure (BP) control has become a worldwide public health priority, and has 
been emphasized on the public health agenda. May 17th is marked as World Hypertension Day 
(5). WHO target is to reduce the relative prevalence of raised blood pressure by 25% in the next 
7 years (8).  Although hypertension is not an inevitable disease, once it develops it often requires 
costly, lifelong treatment with medicines. Thiazide-type diuretics, called water pills acting on the 
kidneys to help the body eliminate sodium and water and reduce blood volume, either alone or 
combined with other types of drugs, are recommended to patients with uncomplicated 
hypertension (7, 9). Most patients with hypertension require two or more antihypertensive drugs 
to achieve their target BP (<130/80 mmHg or < 140/90 mmHg for patients with chronic kidney 
disease or diabetes respectively) (7). When BP becomes >20/10 mmHg above the target BP other 
antihypertensive drug classes such as angiotensin receptor blockers, calcium channel blockers, 
and angiotensin-converting enzyme inhibitors may be needed (7). But patients may still not be 
able to reach their goal BP with the combinations of the above medicines and alpha blockers, 
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alpha-beta blockers, beta blockers, aldosterone antagonists, renin inhibitors, vasodilators, and 
central-acting agents may be prescribed by their doctors for the treatment (9).   
Antihypertensive drugs only adequately maintain BP in about 50% of hypertensive cases (10). 
Lifestyle changes play a very important role in the primary prevention of hypertension. Regular 
physical activity through at least 150 minutes a week of moderate aerobic activity or 75 minutes 
a week of vigorous aerobic activity, a combination of moderate and vigorous activity, interval 
training in which short bursts of intensive activity with short recovery periods of lighter activity 
alternatively taken, or at least two days a week of muscle-strengthening exercises, would help to 
lower the BP as well (9). It was demonstrated that patients receiving exercise interventions 
gained a modest reduction in both systolic (-3.1 mmHg, 95%CI: -0.7 to -5.5) and diastolic (-1.8 
mmHg, 95% CI: -0.2 to -3.5) blood pressure compared to people without interventions (13). 
Increase physical activity not only aids in keeping the body weight under control, but also helps 
to manage stress and reduce the risk of other health problems. It is reported that each kilogram of 
weight lost may reduce BP by about 1 mmHg (9). 
Meanwhile, other lifestyle changes and home remedies have been explored by clinicians as 
reducing salt/sodium in daily diet by putting down the saltshaker and eating less processed foods 
such as canned soups or frozen dishes may contribute to 2-8 mmHg reduction in SBP (7, 9).  
Limiting the intake of to one drink a day for women, and up to two drinks a day for men is 
recommended, since alcohol can raise the BP even in healthy condition. One drink means 12 
ounces of beer, 5 ounces of wine or 1.5 ounces of 80-proof liquor (7,9). Moderation of alcohol 
consumption could lower SBP 2-4 mm Hg (7). Smoking is associated with poor cardiovascular 
and pulmonary outcomes by injuring blood vessel walls and accelerates the process of the 
buildup of plague in the arteries (9, 13). Regular physical activity, plenty of sleep, refusal of 
extra tasks, maintaining good relationships, releasing negative thoughts, and remaining patient 
and optimistic and practicing healthy coping techniques such as muscle relaxation, deep 
breathing and meditation helps manage stress (9). Relaxation interventions were associated with 
statistically significant reductions in systolic (-3.7 mmHg, 95%CI: -1.3 to -6.0) and diastolic (-
3.5 mmHg, 95%CI: -1.9 to -5.1) BP (13). Monitoring BP at home helps to keep a closer eye on 
BP on a daily basis to see if medication working well and to alert the patients and doctors to 
potential complications (9). Some supplements including fiber, such as blond psyllium and wheat 
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bran, folic acid, minerals such as magnesium, calcium, and potassium, Omega-3 fatty acids, the 
products widen blood vessels (vasodilators) such as cocoa, coenzyme Q 10, L-arginine or garlic, 
vitamin D might help lower BP (9). For women, menopausal hormone therapy not raising BP 
should be considered as a form of contraception instead of oral contraceptives that increase the 
risk of hypertension with duration of use. Pregnant women with hypertension should be followed 
very carefully due to the increased risks to both mother and fetus. Methyldopa, beta-blockers, 
and vasodilators are preferred medications for the safety of the fetus (7). Intake of caffeine has 
long being associated with raised BP and demonstrated a dose-related increase of 5-15 mmHg 
systolic and 5-10 mmHg diastolic BP for a few hours. Though caffeine varies based on the 
different beverages, typically coffee contains 60-120 mg caffeine per 150 ml cup compared to 
tea (20 – 40 mg per 150 ml cup) and cola drinks (30-50 mg per 330 ml can). Caffeine acts like an 
adenosine receptor antagonist that leads to vasoconstriction and raised BP. Its half-life in the 
body is about five hours (13). 
Dietary Approaches to Stop Hypertension (DASH) and being physically active are also 
recognized as effective strategies for lowering the BP and maintaining a healthy weight (11). 
DASH highlights the importance of eating healthier foods such as fruits, vegetable, fish, less 
saturated fat and trans-fat dairy foods, whole grains, poultry, fish, and more potassium to help 
prevent and control high BP (9,12). Adopting a DASH eating plan may result in 8-14 mm Hg 
reduction in SBP (7).  Even though DASH emphasizes the beneficial effects of increased 
consumption of nitrate/nitrite-rich food products such as fruits, green leafy and root vegetables 
on BP reduction, and clinical trials have also been conducted to test the effect of dietary intake 
rich in nitrate on the reduction of BP, overall the results are inconsistent (14). The objective of 
this paper is to conduct a systematic review and meta-analysis of randomized clinical trials to 
evaluate the impact of dietary nitrate on BP reduction in humans. The results will inform whether 
inorganic nitrate including dietary nitrate mainly in beetroot supplement can be considered to be 
an effective intervention for the prevention of hypertension. 
Background 
It is documented that the dietary nitrate is first absorbed in the upper gastrointestinal tract and 
then about 25% of the absorbed nitrate is delivered to the salivary gland and secreted into saliva 
where is reduced to nitrite by commensal anaerobic bacteria on the tongue (15).  Acid stomach 
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protonated part of the nitrite into nitrous acid (NO2
- + H+ → HNO2), and then decomposed to a 
variety of nitrogen oxides such as NO, nitrogen dioxides (NO2), and dinitrogen trioxide (N2O3) 
(2 HNO2 → N2O3 + H2O, N2O3 → NO + NO2) (15). The leftover nitrate/nitrite is efficiently 
absorbed in the intestine and enters the bloodstream, where mixing with nitrate from NO 
synthases (NOS), the main endogenous sources (16). Part of the nitrate is excreted in the kidney, 
rest of the nitrate is actively taken up by the salivary glands and circulated in the nitrate-nitrite-
NO pathway (16).  
The NO as an endogenous effector molecule circulating in the body is originated from three 
resources: the diet, endogenous NOS enzyme, and the drugs (Figure 1) (15). NO donor drugs can 
directly produce NO to reduce BP (15). Dietary nitrate/nitrite and NOS producing NO are linked 
to the cyclic guanosine monophosphate (cGMP) functions of NO by mediating local 
vasodilatation (15,17). cGMP as the second messenger of NO is crucial in blood pressure 
regulation and in the etiology of hypertension (17).   
Methods 
Literature search strategies 
We systematically searched PubMed, Web of Science, Embase and PsycInfo for randomized 
clinical trials (RCTs) that evaluated the effect of dietary nitrate supplementation in reducing 
systolic blood pressure (SBP) and diastolic blood pressure (DBP) compared to taking placebo or 
low nitrate supplementation from inception to July 2018. The search was conducted based on 
predefined search terms (dietary, inorganic, nitrate, beetroot, blood pressure, and hypertension). 
Additionally, we manually searched for studies listed in references, in case there were potential 
studies not captured by the database search strategy. We also hand-searched the studies 
published most recently. The search was limited to articles written in English. The present 
systematic review was conducted according to the established PRISMA guidelines (18).  
Inclusion and exclusion criteria 
The inclusion and exclusion criteria for all included papers were established by two researchers. 
The systematic review and meta-analysis only included primary research published in peer-
reviewed journals that: (1) were randomized, parallel or crossover, placebo-controlled designs 
that delivered treatment of nitrate or beetroot supplementation, (2) included adult male and 
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female participants (age greater than18 year-old) with or without health comorbidities, (3) 
investigated the treatment effects on changes in both SBP and DBP. Studies were excluded from 
the meta-analysis if the outcomes were incomplete, for instance, only reported changes in 
average outcomes between treatment and control groups. We further excluded the studies that 
delivered the above supplementation alongside another intervention (e.g. exercise) if the 
interventions were different between groups. 
Study selection and data extraction 
Study selection was conducted in 3 steps. First, the titles and abstracts of studies identified in our 
literature search were independently reviewed by 2 reviewers. Second, the full texts of studies 
retrieved in the initial screening were independently reviewed by 2 reviewers and disagreements 
were reconciled. Third, characteristics of studies that met inclusion criteria and exclusion criteria 
were extracted independently by 3 reviewers, including author, year of publication, study design, 
study’s country, sample size, designs of treatment (duration, dosage and frequency), mean and 
standard deviation of the outcomes in changes adjusted for baseline measurements. Demographic 
information of participants from included studies would be extracted by 3 reviewers, including 
age, sex, and health comorbidities.  
If the outcomes of interest were measured at multiple time points for one cohort, all related 
outcomes were extracted for potential subgroup analysis. If more than one type of dietary nitrate 
intervention were examined within the same trial, for example, high nitrate diet, and the 
combination of high nitrate diet and beetroot juice, all types of interventions were extracted and 
analyzed separately. 
Quality assessment  
The quality of each study was assessed using the Cochrane Risk of Bias Tool to assess the 
following domains: selection bias (random sequence generation and allocation concealment), 
performance bias (blinding of participants and personnel to which intervention a participant 
received), detection bias (blinding of outcome assessment), attrition bias (completeness of 
outcome data, including attrition and exclusions from the analysis), and reporting bias (selective 




Meta-analysis using random-effects model was conducted to evaluate the impact of dietary 
nitrate intervention on the changes of blood pressure (in SBP and DBP, respectively) between 
treatment and control group. Data were presented as mean difference (MD) of changes in SBP 
and DBP (in mm Hg) with corresponding 95% confidence interval (CI). The pooled MD is 
considered statistically significant if 95% CI did not contain 0. Individual and pooled estimates 
were illustrated using forest plots for both SBP and DBP. I2 statistic was calculated to quantify 
the proportion of between-study heterogeneity attributable to variability in the association rather 
than sampling variation, and significant heterogeneity was considered existing if p values 
corresponding to I2 statistic is smaller than 0.05. Potential publication bias was evaluated using 
Egger’s regression test. Subgroup analysis were performed to assess whether changes in diastolic 
and systolic BP were influenced by study duration (<3 vs. ≥3 days), the types of intervention 
(beetroot supplementation vs. other inorganic nitrate), choice of placebo (nitrate-depleted 
beetroot vs. others), and specific population such as age and BMI. Random-effects meta-
regression was implemented to evaluate the impact of age, dosage, and sample size on changes 
in BP outcomes. Sensitivity analysis were conducted to evaluate the robustness of the results. All 
meta-analyses were conducted using ‘meta’, ‘metafor’, and ‘mvmeta’ in R (3.4.4 version). 
Measurement of treatment effects 
Net treatment effects on SBP and DBP respectively were determined by subtracting the mean 
changes of each outcome from baseline to the last available measurement in the control group 
from the corresponding mean changes in the active treatment group (20). We will refer to the 
treatment effects as mean difference in changes in SBP or DBP from here on. Standard errors 
(SEs) of the treatment effects were obtained either directly from the value available in the study, 
or calculated from SDs or CIs when the sample size were described in each trial.  
Results 
Search results  
Initial database search yielded a total of 4,511 records as shown in the flow chart (Figure 2). 
After excluding letters or reviews and eliminating duplicates, 3,322 remained. After the abstract 
screening, 3,218 studies were not relevant and therefore excluded. The 104 remaining reports 
were retrieved in full-text. A total of 41 trials including 733 participants (with 5 to 65 
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participants per study) were enrolled. The main characteristics of the studies included are shown 
in Table 1. The duration of each intervention ranged from 3 hours to 12 weeks with the median 
value of 3 days (25%-75% quartile range equal to 1-7 days).  21 out of 41 studies showed that 
dietary nitrate was associated with a significantly decline in SBP compared to placebo, while 
only 12 out of the 21 above studies indicated that dietary nitrate was also associated with a 
significantly DBP reduction. There were 3 studies where dietary nitrate significantly lower DBP 
but not SBP. Finally, a total of 14 articles were included in our meta-analysis, including 4 for 
randomized parallel and 10 for randomized crossover studies.  
Study characteristics 
The study characteristics of the studies included in the systematic review and meta-analysis were 
shown in Table 1. 
 
Table 1: Main study characteristics of the studies included in the systematic review and meta-
analysis. 









Male            
(%) 


















2013 UK 23 31 100 23.3 healthy 6 hours   
Kim et 
al(23) 















n et al(26) 














12 31 100   healthy 3 days 5 days 
Lansley et 
al(28) 




































2016 Brazil 5 58 80 22.8 healthy 3 hours   
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2008 UK 14 25.5 64.3 22.5 healthy 24hours   
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2017 UK 13 34.5 30.8 27.1   3 days 7 days 
 
Types of treatments / placebos 
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The included studies investigated the effects of dietary nitrate including beetroot 
supplementation (juice/extract), green vegetables (e.g. spinach), combined extracts of green 
vegetables and beetroot supplementation, inorganic nitrate compounds (e.g. Sodium nitrate), and 
NO dietary supplement marketed as a new ‘‘real nitric oxide” molecule (2-(nitrooxy)ethyl 2-
amino-3-methylbutanoate). The placebo involved in lower nitrate (e.g. asparagus soup), the 
negligible nitrate content (e.g. orange juice/black-currant juice), and the nitrate-depleted BR 
juice, though some studies did not describe the details of placebo.  
Demographic characteristics for meta-analysis 
The demographic characteristics of the 14 trials are shown in Table 1 (15, 19, 20, 23, 25, 31, 32, 
34, 35, 40, 45, 51, 54, and 55). The majority of these trials recruited nonsmoking, healthy, young 
participants with the median age of 48 years old ranged from 27 to 62 years old. Half of the 
participants were men. The mean BMI of the participants was 27 kg/m2 with range from 25 to 28 
kg/m2. Two studies was conducted in hypertension individuals, one in overweight individuals, 
one in hypercholesterolemic individuals, and one in diabetes participants. In total, the 14 cohorts 
included 343 participants with 7 to 65 participants per study were enrolled in final meta-analysis. 
The duration of each intervention ranged from 24 hours to 12 weeks with the median value of 7 
days (25%-75% quartile range equal to 3-13 days).   
Study quality  
The RCTs were evaluated by two reviewers (SS, QH) using the Cochrane risk of bias assessment 
tool (19), which evaluated 6 domains including random assignment, allocation concealment, 
blinding of participants, incomplete outcome data, selective outcome reporting, and other sources 
of bias. The assessment of “yes,” “no,” or “unclear” was assigned to each domain for respective 
designation of a low, high, or unclear risk of bias. If “unclear” or “no” was assigned to one or 
less domains, the study was evaluated as having a low risk of bias. If over four domains were 
assigned “unclear” or “no”, the study was evaluated as having a moderate risk (Figure 3). 
Adverse events  
It was reported that adverse events occurred in 16 studies. One study reported gastrointestinal 
and headache, and one trial had mild bloating complaints. The most common side effect 
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documented in 12 studies was beeturia (red urine) and red stools due to the beetroot 
supplementation consumption.  
Meta-analyses 
Overall, beetroot supplementation was associated with a significant reduction in SBP and DBP. 
In specific, the reduction in SBP was significantly higher in beetroot and inorganic nitrate 
supplementation than in the control groups (MD=-3.07, 95% CI: -4.59 to -1.54) without 
heterogeneity (I2=23%, p=0.17) (Figure 4), and the reduction in DBP was significantly higher in 
beetroot and inorganic nitrate supplementation than in the control groups (MD=-1.43, 95% CI: -
2.55 to -0.30) without heterogeneity (I2=21%, p=0.2) (Figure 5).  
Subgroup Analyses 
Table 2 presented the results from subgroup analysis using random-effects meta-analysis 
(Supplemental figures 1-6).  
Table 2: Meta-analysis of random clinical trials reporting the effects of beetroot juice and 
inorganic nitrate supplementation on blood pressure. 
 Studies 
Effect size (mean 
difference (95% CI)) 
P value* I2 
 n mmHg   
Study duration     
     SBP     
 ≤ 3 days 10 -3.26 (-5.67, -0.85) 0.27 18 
> 3 days 9 -2.91 (-5.00, -0.83) 0.14 35 
     DBP     
 ≤ 3 days 10 -1.17 (-3.08, 0.74) 0.13 35 
> 3 days 9 -1.61 (-3.01, -0.21) 0.36 9 
Age     
     SBP     
<50 years old 8 -2.18 (-4.12, -0.24) 0.86 0 
≥ 50 years old 11 -3.52 (-6.05, -1) 0.05 45 
     DBP     
<50 years old 8 0.11 (-1.56, 1.79) 0.63 0 
≥ 50 years old 11 -2.15 (-3.51, -0.79)  0.25 20 
Type of Treatment     
     SBP     
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Beetroot juice 11 -4.68 (-6.57, -2.79) 0.32 13 
Inorganic nitrate 8 -1.12 (-3.02, 0.77) 0.85 0 
     DBP     
Beetroot juice 11 -2.35 (-3.86, -0.84) 0.2 25 
Inorganic nitrate 8 0.06 (-1.47, 1.60) 0.86 0 
Type of Placebo     
     SBP     
Nitrate-depleted 
beetroot 
8 -4.40 (-6.79, -2.01) 0.14 36 
Others 11 -1.57 (-3.33, 0.19) 0.85 0 
     DBP     
Nitrate-depleted 
beetroot 
8 -2.10 (-3.85, -0.35) 0.1 42 
Others 11 -0.35 (-1.82, 1.11) 0.74 0 
Healthy Conditions     
     SBP     
Healthy 12 -2.27 (-4.12, -0.43) 0.94 0 
Disease 7 -3.60 (-6.62, -0.59) 0.01 64 
     DBP     
Healthy 12 -0.40 (-1.92, 1.12) 0.7 0 
Disease 7 -2.02 (-3.77, -0.28) 0.07 48 
BMI     
     SBP     
<25 kg/m2 4 -2.52 (-4.98, -0.07) 0.72 0 
>=25 kg/m2 15 -3.06(-5.06, -1.05) 0.08 36 
     DBP     
<25 kg/m2 4 0.23 (-1.81, 2.27) 0.35 9 
>=25 kg/m2 15 -1.98 (-3.15, -0.80) 0.36 8 
*: P value corresponding to heterogeneity test 
When the meta-analysis stratified by type of intervention, the intervention of beetroot juice 
resulted in significant reduction in both SBP and DBP (MD=-4.68 mmHg, 95% CI: -6.57 to -
2.01, and MD=-2.35 mmHg, 95% CI: -3.86 to -0.84, respectively), while the reduction was not 
significant in inorganic nitrate. Although the reduction for longer study duration (> 3 days) in 
DBP was significantly higher in the treatment groups than in the control groups (MD=-1.61 
mmHg, 95% CI: -3.01 to -0.21), the reduction in DBP for shorter study duration (≤ 3 days) was 
not significantly different between the two groups. The reduction in DBP stratified by age 
indicated that the younger participants (<50 years old) was not significantly different, however 
the reduction for older participants (≥ 50 years old) in DBP was significantly higher in the 
treatment groups than in the control groups (MD=-2.15 mmHg, 95% CI: -3.51 to -0.79). In 
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addition, the reduction in DBP for greater BMI (>=25 kg/m2) was significantly higher in the 
treatment group than in the control group (MD=-1.98 mmHg, 95% CI: -3.15 to -0.80), but there 
was no significant difference in smaller BMI (<25 kg/m2) between the two groups. The subgroup 
analysis by healthy conditions indicated a significant reduction in DBP for disease participants 
(MD=-2.02 mmHg, 95% CI:-3.77 to -0.28), but no significant reduction for healthy participants.  
A significant reduction in both SBP and DBP (MD=-4.40 mmHg, 95% CI: -6.79 to -2.01, and 
MD=-2.10 mmHg, 95% CI: -3.85 to -0.35) was also observed during the stratification by type of 
placebo in the trials using nitrate-depleted beetroot, while the reduction was not significant in 
other controls. The stronger effect size observed in the trials that used nitrate-depleted beetroot 
as a placebo compared with other interventions demonstrated the potential nitrate-dependent 
effects on the blood pressure.  
Publication bias and heterogeneity 
An overall symmetric distribution of the studies around the mean effect size was observed in 
funnel plots for both SBP and DBP, indicating a low risk for publication bias (Supplemental 
Figures 7-8). Egger’s regression test confirmed that nonsignificant publication bias for both SBP 
and DBP (P = 0.19 and 0.72 respectively). There was moderate heterogeneity for SBP (I2 = 23%, 
p = 0.17) and for DBP (I2 = 21%, p =0.20) in the meta-analysis models. 
The subgroup analysis (Table 2) indicated that trials with a longer duration (> 3 days days), older 
participants (≥ 50 years old), overweight participants, and those that used nitrate-depleted 
beetroot as placebos might be potential sources of heterogeneity for SBP outcomes. A shorter 
duration (≤ 3 days), older participants (≥ 50 years old), and those that used nitrate-depleted 
beetroot as placebos might be potential sources of heterogeneity for DBP outcomes. 
Meta-regression  
A meta-regression analysis showed that mean changes in SBP were directly affected by its daily 
dosage of nitrate (P < 0.05); changes in DBP were not affected by the daily dosage of nitrate but 
were negatively correlated with the age of participants (Table 3). 
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Table 3: Meta-regression of potential moderators of blood pressure changes in response to 
beetroot supplementation. 
 Slope  95% CI  P value Q 
SBP     
Age, years  -0.026 -0.121, 0.0694 0.59 0.285 
Daily dosage of nitrate, mM 0.386 0.0224, 0.75 0.038 4.328 
DBP     
Age, years -0.0696 -0.133, -0.0066 0.031 4.68 
Daily dosage of nitrate, mM 0.29 -0.0259, 0.606 0.072 3.24 
Sensitivity analyses  
Sensitivity analyses were conducted to evaluate whether changes in diastolic and systolic BP 
were influenced by potential disease cohorts. A random-effects model was applied to each 
subgroup to obtain the pooled estimate of the mean difference (Table 4). The overall effect of 
intervention on changes in SBP yielded similar results when excluding disease cohorts. 
However, the results became non-significant when excluding the hypertension cohorts, which 
indicated hypertension population would result in the potential differences between groups in 
terms of changes in DBP.  
Table: Sensitivity analysis to evaluate the effects of potential modifying factors on the pooled 
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*: P value comes from heterogeneity I2 
Sensitivity analyses were also conducted to evaluate whether changes in diastolic and systolic 
BP were influenced by the cohorts with gender. A random model was applied to each subgroup 
to obtain the pooled estimate of the mean difference (Table 5). Excluding trials with male only or 
female only did not change the results for either SBP (MD: -2.93 mmHg, 95% CI: -4.69 to -1.17 
and MD: -3.00 mmHg, 95% CI: -4.61 to -1.40, relatively) or DBP (MD: -1.28 mmHg, 95% CI: -
2.50 to -0.06 and MD: -1.45 mmHg, 95% CI: -2.63 to -0.26, relatively). 
Table 5: Sensitivity analysis to evaluate the effects of potential modifying factors on the pooled 










































*: P value corresponding to heterogeneity test 
Discussion 
Our systematic review of 41 randomized studies indicated that the inorganic nitrate diet and 
supplement, separately or together, would lower resting BP compared to the control diet or no 
supplement interventions. The meta-analysis of 14 RCTs showed that beetroot and inorganic 
nitrate supplementation might be associated with significantly lower levels of both SBP and DBP 
(MD: -3.07 mmHg, 95% CI: -4.59 to -1.54 and MD: -1.43 mmHg, 95% CI: -2.55 to -0.30, 
respectively) compared to placebos.  
According to subgroup analyses, the best effect of beetroot and inorganic nitrate supplementation 
on BP was observed when the duration of trial was > 3 days, while both SBP and DBP had 
significant reduction. Previous meta-analyses had reported the same term BP-lowering effects of 
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beetroot and inorganic nitrate, but Siervo and colleagues did not report the significant difference 
in DBP (10).  
Our results also presented that the BP-lowering effects of beetroot and inorganic nitrate 
supplementation may be influenced by chronic disease. A significant reduction was observed in 
DBP after the interventions in diseased and overweight (BMI>=25 kg/m2) participants than in 
healthy participants (MD=-2.02 mmHg, 95% CI:-3.77 to -0.28 and MD=-1.98 mmHg, 95% CI: -
3.15 to -0.80, respectively). Additionally, hypertension participants were discovered to have a 
response to the intervention. 
Our remarkable findings of subgroup analyses were interventions of beetroot juice and nitrate-
depleted placebo contributed to greater effect size on BP reductions  in both SBP and DBP (MD 
in SBP for beetroot juice=-4.68 mmHg, 95% CI: -6.57 to -2.01, MD in DBP for beetroot juice=-
2.35 mmHg, 95% CI: -3.86 to -0.84, MD in SBP for nitrate-depleted placebo=-4.40 mmHg, 95% 
CI: -6.79 to -2.01, and MD in DBP for nitrate-depleted placebo=-2.10 mmHg, 95% CI: -3.85 to -
0.35). In contrast, Zahra and colleagues only reported a weak effect size with nitrate-depleted 
placebo with moderate heterogeneity (62). Our studies demonstrated a potential nitrate-
dependent effect on lowering the blood pressure.  
A greater impact of beetroot and inorganic nitrate supplementation on BP reduction found in 
older subjects was mostly associated with the structural changes in their arteries and especially 
with large artery stiffness. It was reported the elderly had the high risk of increased pulse 
pressure due to the decreased DBP and increased SBP (63). Therefore, we might expect larger 
scope for the treatment to be effective for this outcome and type of subject, because their BPs are 
more extreme to begin with. Our meta-regression analysis also demonstrated that a significant 
negative relationship between age and the treatment effect on DBP after beetroot and inorganic 
nitrate consumption (slope=-0.0696; p=0.031). Though this finding was different from the 
previous reports by Ashor, Siervo and Zahra and their colleagues who had indicated that beetroot 
and inorganic nitrate had a lower effect on the older subjects due to the different level capacity to 
convert NO3 into NO2 (62,64,65). Beetroot and inorganic nitrate supplementation exerts its 
magnificent efforts to lower the BP among various participants.  
Our meta-regression also identified daily dosage of nitrate as a potential moderator of SBP 
changes in response to beetroot and inorganic nitrate supplementation. We found a significant 
positive relationship between daily dosage of nitrate and the treatment effect on SBP after 
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intervention (slope=0.386; p=0.038). It was consistent with the recent reports by Siervo and 
Zahra and their colleagues (10, 62).  
There are some limitations in the meta-analyses. Our broad inclusion criteria for selection and 
qualification of studies may have increased the heterogeneity between studies and made it 
difficult to apply our findings for specific patients, for example, those who have obesity. In 
addition, our searches were limited to English-language and published records, possibly 
increasing the risk of publication bias. 
Conclusion 
Our results showed a beneficial reduction in BP after relatively short-term beetroot 
supplementation, which contributes important new evidence that indicates the hypotensive 
properties of beetroot to be a potentially safe and cost effective nutritional therapy for managing 
hypertension, particularly when internal source of NO suffers from dysfunction. It may also 
potentially have important implications for the prevention of cardiovascular diseases. 
Meanwhile, it implies that dietary nitrate is an essential supplement for the prevention and 
treatment of hypertension that would be able to further prevent undesirable cardiovascular 
disease as well.   
Implications for Public Health Leaders 
While this meta-analysis had demonstrated the effectiveness of dietary nitrate in preventing and 
treating hypertension, there are many cultural and socioeconomic factors having an impact on 
whether people adopt and follow such a diet to control BP. According to the CDC, 
approximately 75% of Americans do not regularly consume enough fruits and more than 50% do 
not eat enough vegetables, while 64% eat too much saturated fat according to CDC (66). This 
behavior comes not only from the knowledge gaps in nutrition but also because of social 
determinants such as economic burden and limited access to healthier foods. The dietary 
problems are associated with health disparities and differentially influence people of different 
culture, race, age and educational level (66). Though the CDC has collaborated with the National 
Cancer Institute (NCI), the American Cancer Society (ACS) and three Department of Agriculture 
agencies to expand federal support for the national “5 A Day for Better Health” Program to help 
health organizations promote fruit and vegetable consumption, the importance of increase dietary 
nitrate has not been included. 
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Interventions to increased dietary nitrate should be one important step to prevent and control 
hypertension. Public health leaders (PHLs) play an important role in integrating this intervention 
into multifaceted programs (e.g. community-based programs, school-based programs and 
healthcare programs). Such  programs should fall into 3 categories: 1) health promotion: to help 
individuals establish an active lifestyle and healthy eating behaviors by increasing nitrate 
consumption early in life and to maintain these behaviors throughout their lives; 2) primary 
prevention: to help individuals who have hypertension or NCDs, prevent or postpone the onset of 
disease by establishing more active lifestyles and healthier eating behaviors such as additional 
intake of nitrate; and 3) secondary prevention: to help individuals who already have hypertension 
or NCDs, control their conditions and prevent further disabilities by increasing their physical 
activity and developing much healthier eating habits (increasing dietary nitrate) (66).  
In order to be most effective in the long run, healthy eating behaviors by consuming enough 
dietary nitrate combined with appropriate physical activity should be initiated in childhood and 
maintained throughout their life. Prevention interventions targeting older children and schools 
are equally important as interventions for adults who are inactive or have poor dietary behaviors 
even though they have not developed hypertension or NCDs.  
All interventions should be appropriately applied to the target populations, and multiple 
strategies might be needed to reach different segments of the population. Interventions may 
address individuals, institutions, communities, policies, or the environment and should be 
implemented in various settings, such as schools, work settings, healthcare facilities and places 
of worship. Interventions would have the best results if they address not only the intentions of 
individuals, but also their social and physical environments, including the social networks and 
organizations that affect them. 
For example, community-based programs implemented at a local level should work with local 
organizations to identify target populations and encourage entire community participation in a 
comprehensive approach that addresses the physical, social, cultural and political environments 
affecting the whole community. PHLs should consider the following steps for the interventions: 
1) conduct community assessments to determine the dietary habits of residents, identify 
interventions that might help improve the incorporation of nitrate diets and identify community 
resources and potential designs that could help build up the interventions; 2) coordinate among 
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different stakeholders to improve dietary nitrate intake; 3) encourage the residents to participate 
in program planning, design, implementation and evaluation to encourage uptake; 4) educate  
public and policy makers about the importance of dietary nitrate; 5) promote broader social and 
environmental changes that complement individual change efforts such as promoting dietary 
nitrate food choices in restaurants, fast-food outlets, cafeterias, vending machines, recreation 
centers and 6) mass-media campaigns, cooperation with the food industry or local agriculture 
department, and implementation of legislation. 
Healthcare programs should collaborate with community partners to establish an integrated 
approach to improve the intake of dietary nitrate. All children and adults enrolled in health care 
plans should have access to appropriate primary and secondary prevention care services related 
to healthy eating behaviors and physical activity. Promotion of healthy eating behaviors and 
physical activity could be part of the benefit packages in these plans. The plans could also 
include healthy eating behaviors especially dietary nitrate and physical activity as indicators in 
the surveillance data they collect. These indicators can be used to evaluate the effectiveness of 
interventions to increase the nitrate diet among patients in the healthcare system and their 
community partners. 
In addition to convincing people to increase dietary nitrate and be more physically active, PHLs 
should work on creating environments, systems, and policies that increase public awareness 
about dietary nitrate and physical activity, eliminate barriers to the consumption of nitrate-rich 
foods, provide explicit support, reinforcement, and inducements to making healthy choices such 
as eating fruits or vegetables instead less healthy foods, change cultural and organizational 
norms,  and establish themselves as partners in planning and decision-making on environmental 
and policy issues that affect people’s eating and physical activity behaviors. 
Finally, a well-built community coalition may also help create environments that serve as passive 
inducements to consuming a high nitrate diet for persons with hypertension by eating five 
servings of fruit and vegetables a day. There are a few potential advantages of working in a 
coalition for this purpose. A well-organized coalition has more power than an individual or 
organization alone to increase access to resources, create strategic alliances and support networks 
and to be a louder voice and to enhance the legitimacy of a cause. (67). For example, through the 
coalition, the parents with children can create new social networks that would strengthen their 
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ability to advocate for increasing the dietary nitrate; local departments can develop long-lasting 
bonds with professional organizations, media group and policymakers to create synergies; the 
local administrators can benefit from the collaborative bonds across racial and socioeconomic 
lines (67). Meanwhile, since developing healthy eating habits is a long complex process, the 
coalition can enhance coordination of services through multifaceted system approaches.  
Overall, PHLs can implement effective interventions that incorporate the individual behavior 
changes to sustainable intake of nitrate diet and environmental changes to encourage and 
promote greater access to healthier food. 
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Figure 1: The NO pathways. NO is originated from the diet, endogenous NOS enzyme, and the 
drugs. Drugs can directly release NO, while NOS and dietary nitrate generate NO linked to the 
cGMP functions of NO.  
 




Figure 3: Risk of bias graph - review authors' judgements about each risk of bias item presented 
as percentages across all included studies.  
 
Figure 4: Forest plot of random clinical trials investigating the effects of beetroot and inorganic 
nitrate supplementation on SBP. Both fixed and random effects was estimated to obtain the 




Figure 5: Forest plot of random clinical trials investigating the effects of beetroot and inorganic 
nitrate supplementation on DBP. Both fixed and random effects was estimated to obtain the 















Figure 1 Forest plot of the meta-analysis in random clinical trials investigating the effects of 
beetroot and inorganic nitrate supplementation on SBP was stratified by the age (<50, ≥50 years 
old). Both fixed and random models were applied to each group to obtain the pooled mean 





Figure 2 Forest plot of the meta-analysis in random clinical trials investigating the effects of 
beetroot and inorganic nitrate supplementation on DBP was stratified by the age (<50, ≥50 years 
old). Both fixed and random models were applied to each group to obtain the pooled mean 




Figure 3 Forest plot of the meta-analysis in random clinical trials investigating the effects of 
beetroot and inorganic nitrate supplementation on SBP was stratified by the study duration (≤72 
hours, >72 hours). Both fixed and random models were applied to each group to obtain the 




Figure 4 Forest plot of the meta-analysis in random clinical trials investigating the effects of 
beetroot and inorganic nitrate supplementation on DBP was stratified by the study duration (≤72 
hours, >72 hours). Both fixed and random models were applied to each group to obtain the 





Figure 5 Forest plot of the meta-analysis in random clinical trials investigating the effects of 
beetroot and inorganic nitrate supplementation on SBP was stratified by the healthy conditions 
(top: healthy, bottom: disease). Both fixed and random models were applied to each group to 
obtain the pooled mean differences in SBP.  
 
 
Figure 6 Forest plot of the meta-analysis in random clinical trials investigating the effects of 
beetroot and inorganic nitrate supplementation on DBP was stratified by the healthy conditions 
(top: healthy, bottom: disease). Both fixed and random models were applied to each group to 




Figure 7 Funnel plot of random clinical trials investigating the heterogeneity of beetroot and 




Figure 8 Funnel plot of random clinical trials investigating the heterogeneity of beetroot and 
inorganic nitrate supplementation on DBP.  
 
 
